Program chair Navel Daver, MD, invites you to PER®’s complimentary in-person and virtual satellite symposium.
Join Navel Daver, MD, and other leading experts at PER’s Reshaping Higher-Risk MDS Patient-Centered Care with Emergence of Novel Evidence and Clinical Trials on June 4, 2022.
Choosing Between HLA-Mismatched Unrelated and Haploidentical Donors: Donor Age Considerations
July 30th 2025Researchers have found that donor age is a key determinant of outcomes in hematopoietic cell transplantation, with younger donors associated with significantly better survival and lower rates of GVHD.